Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
WELL Health Technologies Corp ( (TSE:WELL) ) has provided an announcement.
WELL Health Technologies Corp’s subsidiary, WELLSTAR, has updated its fiscal 2025 guidance, projecting $74 million in total revenue and $22 million in Adjusted EBITDA, driven by strong organic growth and a robust acquisition pipeline. The company has executed three letters of intent for acquisitions expected to significantly boost its annual recurring revenue and expand its digital health platform, while its Nexus AI solution is gaining traction among clinicians, positioning WELLSTAR as a leader in Canadian digital health.
The most recent analyst rating on (TSE:WELL) stock is a Buy with a C$6.00 price target. To see the full list of analyst forecasts on WELL Health Technologies Corp stock, see the TSE:WELL Stock Forecast page.
Spark’s Take on TSE:WELL Stock
According to Spark, TipRanks’ AI Analyst, TSE:WELL is a Neutral.
The overall stock score reflects strong corporate events and positive technical momentum, offset by valuation concerns due to negative earnings. Financial performance shows growth potential but is hindered by profitability challenges and rising debt levels.
To see Spark’s full report on TSE:WELL stock, click here.
More about WELL Health Technologies Corp
WELL Health Technologies Corp is a company focused on leveraging technology to empower healthcare providers and their patients, aiming to positively impact health outcomes. The company operates in the digital health industry, offering solutions that enhance healthcare delivery and efficiency.
Average Trading Volume: 928,415
Technical Sentiment Signal: Buy
Current Market Cap: C$1.18B
Learn more about WELL stock on TipRanks’ Stock Analysis page.